Study of Gamma Interfereon in Metastatic Colorectal Carcinoma
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evalute the response and toxicity of metastatic colorectal
cancer patients to the regimen of gamma interferon added to bolus and infusional
5-fluorouracil and leucovorin (GFL) with or without bevacizumab.